CS193507B2 - Method of producing hexahydro dibenzo/b,d/pyranes - Google Patents

Method of producing hexahydro dibenzo/b,d/pyranes

Info

Publication number
CS193507B2
CS193507B2 CS747515A CS751574A CS193507B2 CS 193507 B2 CS193507 B2 CS 193507B2 CS 747515 A CS747515 A CS 747515A CS 751574 A CS751574 A CS 751574A CS 193507 B2 CS193507 B2 CS 193507B2
Authority
CS
Czechoslovakia
Prior art keywords
pyranes
producing
hexahydro dibenzo
dibenzo
producing hexahydro
Prior art date
Application number
CS747515A
Other languages
Czech (cs)
English (en)
Inventor
Robert A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS193507B2 publication Critical patent/CS193507B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
CS747515A 1973-11-05 1974-11-04 Method of producing hexahydro dibenzo/b,d/pyranes CS193507B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (1)

Publication Number Publication Date
CS193507B2 true CS193507B2 (en) 1979-10-31

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
CS747515A CS193507B2 (en) 1973-11-05 1974-11-04 Method of producing hexahydro dibenzo/b,d/pyranes

Country Status (26)

Country Link
US (1) US3968125A (pl)
JP (1) JPS6033835B2 (pl)
AR (1) AR202318A1 (pl)
AT (1) AT336012B (pl)
BE (1) BE821716A (pl)
BG (1) BG26387A3 (pl)
CA (1) CA1023753A (pl)
CH (1) CH605894A5 (pl)
CS (1) CS193507B2 (pl)
DD (1) DD116230A5 (pl)
DE (1) DE2451934C2 (pl)
DK (1) DK136719B (pl)
ES (1) ES431674A1 (pl)
FR (1) FR2249664B1 (pl)
GB (1) GB1487637A (pl)
HU (1) HU169193B (pl)
IE (1) IE40023B1 (pl)
IL (1) IL45644A (pl)
NL (1) NL7414439A (pl)
PH (1) PH11788A (pl)
PL (2) PL93908B1 (pl)
RO (1) RO71766A (pl)
SE (1) SE415762B (pl)
SU (1) SU524517A3 (pl)
YU (1) YU36515B (pl)
ZA (1) ZA745751B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (pl) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JPWO2003070277A1 (ja) * 2002-02-19 2005-06-09 塩野義製薬株式会社 抗掻痒剤
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
JP2010535238A (ja) * 2007-07-30 2010-11-18 オールトランツ インコーポレイティド カンナビジオールのプロドラッグ、カンナビジオールのプロドラッグを含む組成物及びその使用方法
WO2009099670A2 (en) * 2008-02-08 2009-08-13 Nektar Therapeutics Al, Corporation Oligomer-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2019016814A1 (en) 2017-07-20 2019-01-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. PHARMACEUTICAL FILM COMPOSITIONS FOR THE ADMINISTRATION OF LIPOPHILIC COMPOUNDS IN AND / OR THROUGH THE SKIN
EP3681474A1 (en) 2017-09-11 2020-07-22 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions and methods for nasal administration of drugs to brain and for systemic effect
CA3116187A1 (en) 2017-11-29 2019-06-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
CA3116194A1 (en) 2018-11-04 2020-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
DE2451934C2 (de) 1983-10-06
AU7321274A (en) 1976-03-18
RO71766A (ro) 1982-12-06
IL45644A0 (en) 1974-11-29
ATA886374A (de) 1976-08-15
FR2249664A1 (pl) 1975-05-30
IE40023B1 (en) 1979-02-28
SE7413833L (pl) 1975-05-06
AR202318A1 (es) 1975-05-30
US3968125A (en) 1976-07-06
PL95748B1 (pl) 1977-11-30
PL93908B1 (pl) 1977-07-30
FR2249664B1 (pl) 1978-03-24
YU36515B (en) 1984-02-29
DE2451934A1 (de) 1975-05-07
DK136719C (pl) 1978-04-24
HU169193B (pl) 1976-10-28
AT336012B (de) 1977-04-12
DD116230A5 (pl) 1975-11-12
BG26387A3 (pl) 1979-03-15
CA1023753A (en) 1978-01-03
IL45644A (en) 1978-03-10
DK136719B (da) 1977-11-14
SU524517A3 (ru) 1976-08-05
DK573274A (pl) 1975-07-07
SE415762B (sv) 1980-10-27
JPS5071678A (pl) 1975-06-13
BE821716A (fr) 1975-04-30
CH605894A5 (pl) 1978-10-13
NL7414439A (nl) 1975-05-07
YU265874A (en) 1982-02-25
JPS6033835B2 (ja) 1985-08-05
ZA745751B (en) 1976-04-28
GB1487637A (en) 1977-10-05
PH11788A (en) 1978-07-05
ES431674A1 (es) 1976-11-16
IE40023L (en) 1975-05-05

Similar Documents

Publication Publication Date Title
CS193507B2 (en) Method of producing hexahydro dibenzo/b,d/pyranes
CS193506B2 (en) Method of producing novel hexahydro dibenzo/b,d/pyrane-9-ones
IL45185A0 (en) Process for producing o-methylbenzanilide
HU172680B (hu) Sposob poluchenija dinitrila malonnojj kisloty
CS186263B2 (en) Method for producing novel 1-phenoxy-2-hydroxy-3-propargyl aminopropanes
IL45461A0 (en) A method of preparing bromine
HU172160B (hu) Sposob poluchenija sul'famoilfenil-azapurinonov
HK28279A (en) Improved process for producing a-6-deoxytetracyclines
HU171243B (hu) Sposob poluchenija novykh dotriakontapeptidamidov
CS182260B2 (en) Method of producing 1,3-oxidated 8alfa-estratrienes
YU22874A (en) Process for obtaining diazepine derivatves
HU171074B (hu) Sposob poluchenija novykh 11-beta-alkil-3-dezokso-del'ta vverkh 4-steroedov v pjade estrana
HU172606B (hu) Sposob izgotovlenija sverlil'nykh patronov
CS186280B2 (en) Method for producing 6-fluoralkyl-2,3-quinoxaline diones
ZA742052B (en) Process for producing quinoxaline-di-n-oxides
GB1406566A (en) Method for producing pipes
CS183691B2 (en) Method for producing alkylsulphobenzylpenicillins
CS179443B2 (en) Method for producing phtalazino 2,3-b phtalazine-5/14h/,12/7h/-dione
CS183695B2 (en) Method for producing novel alfa-/o-sulphobenzimido/lactams
CS193482B2 (en) Microorganisms production method
HU173715B (hu) Sposob poluchenija zamehhennykh 2-benzoil-piridinov
AU7226974A (en) Method
HU171218B (hu) Sposob poluchenija 6-skobka-al'fa-di-zamehhennykh-acetamido-skobka zakryta-2,2-dimetil-penam-3-karbonovykh kislot
HU167976B (en) Process for producing new substituted n-carbamoyl-acetamidines
HU171419B (hu) Sposob poluchenija novykh oksoalkil-piridinov